Sign in

You're signed outSign in or to get full access.

Jon Biro

Chairman of the Board at Perma-Pipe International Holdings
Board

About Jon C. Biro

Independent director appointed in February 2025; age 59. Jon Biro is a CPA and seasoned financial executive with prior public-company CFO roles (Harte Hanks, Exterran, Consolidated Graphics, ICO, Inc.), audit training at PricewaterhouseCoopers, and board experience at Aspect Medical Systems and Crown Crafts. He holds a B.A. in Psychology with a minor in Economics from The University of Texas at Austin and an M.S. in Accountancy from the University of Houston; currently serves as an Operating Partner/Consultant to Snow Peak Capital, LLC and sits on private-company boards (Sandy Alexander; Vision Plastics New Zealand). The Board cites his extensive finance, governance, and oil & gas industry knowledge as qualifications to serve .

Past Roles

OrganizationRoleTenureCommittees/Impact
Harte Hanks (public)Chief Financial OfficerNot disclosed Finance leadership; public company reporting
Exterran (public)Chief Financial OfficerNot disclosed Finance; oilfield services expertise
Consolidated Graphics (public)Chief Financial OfficerNot disclosed Finance; commercial printing exposure
ICO, Inc. (public)Board Member; Interim CEONot disclosed Governance and operational leadership
PricewaterhouseCoopersAuditorEarly career (not dated) Audit and accounting foundations

External Roles

OrganizationRoleTenurePublic/PrivateNotes
Snow Peak Capital, LLCOperating Partner & ConsultantSince 2021 PrivatePortfolio operations advisory
Sandy AlexanderBoard MemberNot disclosed PrivateCommercial printing portfolio company
Vision Plastics New Zealand Ltd.Board MemberNot disclosed PrivatePlastics processing
Aspect Medical SystemsPublic Company Board Member (prior)Not disclosed Public (prior)Prior public directorship
Crown CraftsPublic Company Board Member (prior)Not disclosed Public (prior)Prior public directorship

Board Governance

  • Committee memberships: Audit Committee; Nominating & Corporate Governance Committee; Compensation Committee. All members of these committees are independent under SEC and NASDAQ rules .

  • Committee chair roles: Audit Committee chaired by David B. Brown; Nominating & Corporate Governance chaired by Robert J. McNally; Compensation Committee chaired by David B. Brown; Independent Chairman serves as ex-officio non-paid member of all committees .

  • Audit Committee financial expert: The Board determined that Brown, Biro, and McNally qualify as “audit committee financial experts” under SEC regulations .

  • Independence: Four of five nominees are independent; committee independence affirmed above .

  • Attendance: Company expects full engagement; in 2024, directors attended at least 75% of Board and committee meetings; all directors attended the 2024 Annual Meeting (contextual; Biro appointed in 2025) .

  • Meeting cadence (2024):

    BodyNumber of Meetings
    Board of Directors8
    Audit Committee9
    Nominating & Corporate Governance5
    Compensation Committee7
    Unanimous Consent8
  • Governance policies: Majority voting in uncontested elections adopted Feb 19, 2025; anti-hedging/pledging; ownership guidelines; refreshed charters (Audit Apr 2025; Nominating Sep 2024; Compensation Dec 2024) .

  • Clawback: Robust recoupment policy covering restatements and misconduct, with multiple recovery mechanisms; referenced in 10-K Exhibit 97 .

Fixed Compensation

  • 2025 director compensation schedule:

    ComponentAmount (USD)
    Annual cash retainer – Non-Employee Director$45,000
    Independent Chairman additional retainer$40,000
    Audit Chair$10,000
    Audit Member$7,500
    Compensation Chair$7,500
    Compensation Member$6,000
    Nominating & Governance Chair$5,000
    Nominating & Governance Member$5,000
    Annual equity grant – Non-Employee Director$75,000 (RS)
    Annual equity grant – Independent Chairman$85,000 (RS)
  • 2024 director grant details (equity vesting and share counts):

    Grant DatePricing BasisChairman SharesOther Director SharesVesting
    July 25, 202430-day avg closing price $8.819,644 8,509 1-year vest
  • Special projects compensation: Policy created Dec 2024; $85,000 total awarded to four independent directors in Jan 2025 (pre-Biro appointment) .

  • 2024 non-employee directors’ compensation summary (Biro appointed in Feb 2025; no 2024 fees):

    NameCash FeesStock AwardsSpecial Project CompTotal
    Jon C. Biro— (appointed Feb 2025; no 2024 fees)

Performance Compensation

  • Director equity structure: Independent non-employee directors receive annual restricted stock grants that vest over one year; directors may use 10b5-1 plans post-vesting to sell shares for tax coverage .
  • Performance metrics tied to director compensation: Not disclosed (company’s performance-based LTIs and ROE targets pertain to executives, not directors) .
Performance MetricApplicable to Director Pay?Notes
TSR percentileNot disclosed for directors Exec LTIs include ROE-based component; directors receive time-based RS
ROE targetsNot disclosed for directors Executive LTIs include multi-year consolidated ROE targets
ESG goalsNot disclosed for directors No director-specific metrics disclosed

Other Directorships & Interlocks

Company/OrganizationRolePublic/PrivatePotential Interlock/Conflict
Snow Peak Capital portfolio (Sandy Alexander)Board MemberPrivate No related-party transactions disclosed in 2024
Vision Plastics New Zealand Ltd.Board MemberPrivate No related-party transactions disclosed in 2024
Aspect Medical SystemsPrior Public Board MemberPublic (prior) None disclosed
Crown CraftsPrior Public Board MemberPublic (prior) None disclosed
  • Related party and conflicts: Company reports no related party transactions in 2024; anti-hedging/pledging and insider trading pre-clearance required .

Expertise & Qualifications

  • Audit committee financial expert designation (SEC-defined) .
  • Deep finance, accounting, corporate governance, and oil & gas sector experience .
  • Board skills matrix highlights corporate governance, finance, capital markets, risk, cybersecurity, and international experience across nominees; Biro’s biography underscores finance and governance strengths .

Equity Ownership

  • Beneficial ownership as of April 28, 2025:

    HolderShares OwnedOptionsDeferred SharesTotal% Outstanding
    Jon C. Biro1,7221,722<0.5%
  • Unvested shares: As of April 28, 2025, Biro held 1,722 unvested RS with no voting rights .

  • Ownership guidelines:

    GroupGuideline MultipleCompliance Status
    Independent Directors3.0x Annual Base Cash RetainerAll directors “in compliance” with guideline framework; Biro had not received grants as of Jan 31, 2025 and shows “No” achieved status but has 5 years to meet guidelines
  • Hedging/pledging: Prohibited; directors must pre-notify CEO/CFO for securities transactions .

  • Pledging of shares: Prohibited (RED FLAG mitigated) .

Governance Assessment

  • Strengths:

    • Triple-committee membership and independence enhance board oversight; audit financial expert designation strengthens financial reporting and controls .
    • Majority voting in uncontested elections and refreshed committee charters signal governance quality; anti-hedging/pledging and clawback policies align with investor protection .
    • Ownership guidelines (3x retainer for directors) and one-year vesting improve alignment and transparency; directors have five years to reach targets .
  • Watch items:

    • New appointee with small current equity position (1,722 unvested shares) and not yet meeting guideline “achieved” status as of Jan 31, 2025; however, within the compliance window (5 years) .
    • External private board roles and consulting (Snow Peak Capital portfolio companies) should continue to be monitored for any potential related-party dealings; company reports none in 2024 .
  • Attendance and engagement:

    • Company-standard: directors expected to attend Board/committee meetings and Annual Meeting; 2024 attendance ≥75% and full Annual Meeting attendance (contextual to culture; Biro appointed in 2025) .
  • Compensation structure:

    • Competitive director pay confirmed by Willis Towers Watson; 2025 program unchanged; equity is time-based RS, not performance-based—consistent with market practice, but performance-linked director pay is not used .
  • RED FLAGS:

    • None identified in the proxy for Biro: no related-party transactions; hedging/pledging prohibited; no pledging disclosed; no attendance issues disclosed .

Overall implication: Biro’s audit expertise and multi-industry finance background bolster board effectiveness, with current safeguards (clawback, anti-hedging, majority voting) supporting investor confidence. Equity alignment should improve as grants vest and guideline accumulation progresses over the 5-year window .